Intraprocedural tissue diagnosis during ERCP employing a new cytology preparation of forceps biopsy (Smash protocol)

Eric R. Wright, Gennadiy Bakis, Ramesh Srinivasan, Ramu Raju, Harsha Vittal, Michael K. Sanders, Kirk Bernadino, Andreas Stefan, Hagen Blaszyk, Douglas A. Howell

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objectives:Techniques of tissue sampling at endoscopic retrograde cholangiopancreatography (ERCP) have been underutilized due to technical demands, low yield, and lack of immediate intraprocedural diagnosis. The objective of this study was to describe a new inexpensive, highly efficient ERCP tissue processing, and interpretation technique to address these issues.Methods:A retrospective, institutional review board approved, single-center study was done at a tertiary-care medical center. Between June 2004 and February 2009, 133 patients (age 38-95 years; men 53%) with suspicious biliary strictures underwent ERCP with tissue sampling using a new technique. Small forceps biopsy specimens were forcefully smashed between two dry glass slides, immediately fixed, stained with rapid Papanicolaou, and interpreted by an on-site pathologist during the procedure (Smash protocol).Results:Of the 117 proven to have cancer, true-positive Smash preps included pancreatic cancer 49/66 (74%), cholangiocarcinoma 23/29 (79%), metastatic cancer 8/15 (53%), and other 4/7 (57%). The median number of Smash biopsies to diagnosis was 3 (range 1-17). Suspicious or atypical results were considered to be negative in this study. There were no false positives and no complications. Smash had an overall sensitivity of 89/117 (76%) for all cases. The true-positive yield of immediate Smash prep cytology, combined with ERCP fine needle aspirate (FNA) and forceps biopsy histology was 77/95 (81%) for primary pancreaticobiliary cancers.Conclusions:Immediate cytopathologic diagnosis at ERCP was established in 72% of patients presenting with suspected malignant biliary obstruction using a new cytological preparation of forceps biopsies. This approach to ERCP tissue sampling permits immediate diagnosis and avoids the need for subsequent procedures, adds little cost and time, and is safe to perform.

Original languageEnglish (US)
Pages (from-to)294-299
Number of pages6
JournalAmerican Journal of Gastroenterology
Volume106
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Endoscopic Retrograde Cholangiopancreatography
Surgical Instruments
Cell Biology
Biopsy
Neoplasms
Cholangiocarcinoma
Research Ethics Committees
Pancreatic Neoplasms
Tertiary Care Centers
Needles
Glass
Histology
Pathologic Constriction
Costs and Cost Analysis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Wright, E. R., Bakis, G., Srinivasan, R., Raju, R., Vittal, H., Sanders, M. K., ... Howell, D. A. (2011). Intraprocedural tissue diagnosis during ERCP employing a new cytology preparation of forceps biopsy (Smash protocol). American Journal of Gastroenterology, 106(2), 294-299. https://doi.org/10.1038/ajg.2010.447

Intraprocedural tissue diagnosis during ERCP employing a new cytology preparation of forceps biopsy (Smash protocol). / Wright, Eric R.; Bakis, Gennadiy; Srinivasan, Ramesh; Raju, Ramu; Vittal, Harsha; Sanders, Michael K.; Bernadino, Kirk; Stefan, Andreas; Blaszyk, Hagen; Howell, Douglas A.

In: American Journal of Gastroenterology, Vol. 106, No. 2, 02.2011, p. 294-299.

Research output: Contribution to journalArticle

Wright, ER, Bakis, G, Srinivasan, R, Raju, R, Vittal, H, Sanders, MK, Bernadino, K, Stefan, A, Blaszyk, H & Howell, DA 2011, 'Intraprocedural tissue diagnosis during ERCP employing a new cytology preparation of forceps biopsy (Smash protocol)', American Journal of Gastroenterology, vol. 106, no. 2, pp. 294-299. https://doi.org/10.1038/ajg.2010.447
Wright, Eric R. ; Bakis, Gennadiy ; Srinivasan, Ramesh ; Raju, Ramu ; Vittal, Harsha ; Sanders, Michael K. ; Bernadino, Kirk ; Stefan, Andreas ; Blaszyk, Hagen ; Howell, Douglas A. / Intraprocedural tissue diagnosis during ERCP employing a new cytology preparation of forceps biopsy (Smash protocol). In: American Journal of Gastroenterology. 2011 ; Vol. 106, No. 2. pp. 294-299.
@article{e12846d444aa4472906601fe2cc92850,
title = "Intraprocedural tissue diagnosis during ERCP employing a new cytology preparation of forceps biopsy (Smash protocol)",
abstract = "Objectives:Techniques of tissue sampling at endoscopic retrograde cholangiopancreatography (ERCP) have been underutilized due to technical demands, low yield, and lack of immediate intraprocedural diagnosis. The objective of this study was to describe a new inexpensive, highly efficient ERCP tissue processing, and interpretation technique to address these issues.Methods:A retrospective, institutional review board approved, single-center study was done at a tertiary-care medical center. Between June 2004 and February 2009, 133 patients (age 38-95 years; men 53{\%}) with suspicious biliary strictures underwent ERCP with tissue sampling using a new technique. Small forceps biopsy specimens were forcefully smashed between two dry glass slides, immediately fixed, stained with rapid Papanicolaou, and interpreted by an on-site pathologist during the procedure (Smash protocol).Results:Of the 117 proven to have cancer, true-positive Smash preps included pancreatic cancer 49/66 (74{\%}), cholangiocarcinoma 23/29 (79{\%}), metastatic cancer 8/15 (53{\%}), and other 4/7 (57{\%}). The median number of Smash biopsies to diagnosis was 3 (range 1-17). Suspicious or atypical results were considered to be negative in this study. There were no false positives and no complications. Smash had an overall sensitivity of 89/117 (76{\%}) for all cases. The true-positive yield of immediate Smash prep cytology, combined with ERCP fine needle aspirate (FNA) and forceps biopsy histology was 77/95 (81{\%}) for primary pancreaticobiliary cancers.Conclusions:Immediate cytopathologic diagnosis at ERCP was established in 72{\%} of patients presenting with suspected malignant biliary obstruction using a new cytological preparation of forceps biopsies. This approach to ERCP tissue sampling permits immediate diagnosis and avoids the need for subsequent procedures, adds little cost and time, and is safe to perform.",
author = "Wright, {Eric R.} and Gennadiy Bakis and Ramesh Srinivasan and Ramu Raju and Harsha Vittal and Sanders, {Michael K.} and Kirk Bernadino and Andreas Stefan and Hagen Blaszyk and Howell, {Douglas A.}",
year = "2011",
month = "2",
doi = "10.1038/ajg.2010.447",
language = "English (US)",
volume = "106",
pages = "294--299",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Intraprocedural tissue diagnosis during ERCP employing a new cytology preparation of forceps biopsy (Smash protocol)

AU - Wright, Eric R.

AU - Bakis, Gennadiy

AU - Srinivasan, Ramesh

AU - Raju, Ramu

AU - Vittal, Harsha

AU - Sanders, Michael K.

AU - Bernadino, Kirk

AU - Stefan, Andreas

AU - Blaszyk, Hagen

AU - Howell, Douglas A.

PY - 2011/2

Y1 - 2011/2

N2 - Objectives:Techniques of tissue sampling at endoscopic retrograde cholangiopancreatography (ERCP) have been underutilized due to technical demands, low yield, and lack of immediate intraprocedural diagnosis. The objective of this study was to describe a new inexpensive, highly efficient ERCP tissue processing, and interpretation technique to address these issues.Methods:A retrospective, institutional review board approved, single-center study was done at a tertiary-care medical center. Between June 2004 and February 2009, 133 patients (age 38-95 years; men 53%) with suspicious biliary strictures underwent ERCP with tissue sampling using a new technique. Small forceps biopsy specimens were forcefully smashed between two dry glass slides, immediately fixed, stained with rapid Papanicolaou, and interpreted by an on-site pathologist during the procedure (Smash protocol).Results:Of the 117 proven to have cancer, true-positive Smash preps included pancreatic cancer 49/66 (74%), cholangiocarcinoma 23/29 (79%), metastatic cancer 8/15 (53%), and other 4/7 (57%). The median number of Smash biopsies to diagnosis was 3 (range 1-17). Suspicious or atypical results were considered to be negative in this study. There were no false positives and no complications. Smash had an overall sensitivity of 89/117 (76%) for all cases. The true-positive yield of immediate Smash prep cytology, combined with ERCP fine needle aspirate (FNA) and forceps biopsy histology was 77/95 (81%) for primary pancreaticobiliary cancers.Conclusions:Immediate cytopathologic diagnosis at ERCP was established in 72% of patients presenting with suspected malignant biliary obstruction using a new cytological preparation of forceps biopsies. This approach to ERCP tissue sampling permits immediate diagnosis and avoids the need for subsequent procedures, adds little cost and time, and is safe to perform.

AB - Objectives:Techniques of tissue sampling at endoscopic retrograde cholangiopancreatography (ERCP) have been underutilized due to technical demands, low yield, and lack of immediate intraprocedural diagnosis. The objective of this study was to describe a new inexpensive, highly efficient ERCP tissue processing, and interpretation technique to address these issues.Methods:A retrospective, institutional review board approved, single-center study was done at a tertiary-care medical center. Between June 2004 and February 2009, 133 patients (age 38-95 years; men 53%) with suspicious biliary strictures underwent ERCP with tissue sampling using a new technique. Small forceps biopsy specimens were forcefully smashed between two dry glass slides, immediately fixed, stained with rapid Papanicolaou, and interpreted by an on-site pathologist during the procedure (Smash protocol).Results:Of the 117 proven to have cancer, true-positive Smash preps included pancreatic cancer 49/66 (74%), cholangiocarcinoma 23/29 (79%), metastatic cancer 8/15 (53%), and other 4/7 (57%). The median number of Smash biopsies to diagnosis was 3 (range 1-17). Suspicious or atypical results were considered to be negative in this study. There were no false positives and no complications. Smash had an overall sensitivity of 89/117 (76%) for all cases. The true-positive yield of immediate Smash prep cytology, combined with ERCP fine needle aspirate (FNA) and forceps biopsy histology was 77/95 (81%) for primary pancreaticobiliary cancers.Conclusions:Immediate cytopathologic diagnosis at ERCP was established in 72% of patients presenting with suspected malignant biliary obstruction using a new cytological preparation of forceps biopsies. This approach to ERCP tissue sampling permits immediate diagnosis and avoids the need for subsequent procedures, adds little cost and time, and is safe to perform.

UR - http://www.scopus.com/inward/record.url?scp=79751536754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79751536754&partnerID=8YFLogxK

U2 - 10.1038/ajg.2010.447

DO - 10.1038/ajg.2010.447

M3 - Article

C2 - 21102569

AN - SCOPUS:79751536754

VL - 106

SP - 294

EP - 299

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 2

ER -